Whittemore A D, Clowes A W, Hechtman H B, Mannick J A
Ann Surg. 1980 Sep;192(3):414-21. doi: 10.1097/00000658-198009000-00017.
Recent advances in the operative management of aortic aneurysms have resulted in a decreased rate of morbidity and mortality. In 1972, we hypothesized that a further reduction in operative mortality might be obtained with controlled perioperative fluid management based on data provided by the thermistor-tipped pulmonary artery balloon catheter. From 1972 to 1979 a flow directed pulmonary artery catheter was inserted in each of 110 consecutive patients prior to elective or urgent repair of nonruptured infrarenal aortic aneurysms. The slope of the left ventricular performance curve was determined preoperatively by incremental infusions of salt-poor albumin and Ringer's lactate solution. With each increase in the pulmonary arterial wedge pressure (PAWP), the cardiac index (CI) was measured. The PAWP was then maintained intra- and postoperatively at levels providing optimal left ventricular performance for the individual patient. There were no 30-day operative deaths among the patients in this series and only one in-hospital mortality (0.9%), four months following surgery. The five-year cumulative survival rate for patients in the present series was 84%, a rate which does not differ significantly from that expected for a normal age-corrected population. Since the patient population was unselected and there were no substantial alterations in operative technique during the present period, these improved results support the hypothesis that operative mortality attending the elective or urgent repair of abdominal aortic aneurysm can be minimized by maintenance of optimal cardiac performance with careful attention to fluid therapy during the perioperative period.
主动脉瘤手术治疗的最新进展已使发病率和死亡率有所降低。1972年,我们基于热敏电阻尖端肺动脉球囊导管提供的数据推测,通过围手术期液体管理的控制,可能会进一步降低手术死亡率。1972年至1979年,在连续110例择期或急诊修复未破裂肾下腹主动脉瘤的患者术前,均插入了血流导向肺动脉导管。术前通过递增输注低钠白蛋白和乳酸林格液来确定左心室功能曲线的斜率。随着肺动脉楔压(PAWP)的每次升高,测量心脏指数(CI)。然后在术中和术后将PAWP维持在为个体患者提供最佳左心室功能的水平。该系列患者中无30天手术死亡病例,术后四个月仅有1例院内死亡(0.9%)。本系列患者的五年累积生存率为84%,与正常年龄校正人群的预期生存率无显著差异。由于本研究未对患者群体进行选择,且在此期间手术技术无重大改变,这些改善的结果支持了以下假设:在围手术期通过密切关注液体治疗以维持最佳心脏功能,可将择期或急诊修复腹主动脉瘤的手术死亡率降至最低。